Author: VBS

November 2020 Lim TH, Lai TYY, Takahashi K et al. Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial. JAMA Ophthalmol. Sept 2020; 138(9): 935-942. Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration characterized by aneurysmal polypoidal lesions best imaged with […]

Written by: Katherine E. Talcott, MD October 2020 Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA, C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial, Ophthalmology (2020), doi: https://doi.org/10.1016/j.ophtha.2020.08.027. While there are multiple treatment […]

Written by: Prethy Rao, MD MPH October 2020 Okada M, Cordeiro Sousa D, Fabinyi DCA, Hadoux X, Edwards TL, Brown KD, Chiu D, Dawkins RCH, Allen PJ, Yeoh J, Van Wijngaarden. Ophthalmology Retina. Article in Press. In the era of COVID-19 and concerns of transmission during ophthalmic surgery, retina specialists are faced with continued concerns […]

Written by: Maxwell S. Stem, MD September 2020 Khanani AM, Patel SS, Ferrone PJ, Osborne A, Sahni J, Grzeschik S, Basu K, Ehrlich JS, Haskova Z, Dugel PU. Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration (The STAIRWAY Phase 2 Randomized Clinical Trial). JAMA Ophthalmol. 2020;138(9):964-972. […]

Written by: Mehnaz Khan, MD September 2020 Khurana RN, Chang L, Day BM, Ghanekar A, Stoilov I. Timing of Peak Vision Gains in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab. Ophthalmol Retina. 2020;4(8):760-766. doi:10.1016/j.oret.2020.02.011 It is widely accepted that the treatment of neovascular age-related macular degeneration (nAMD) includes intravitreal injections of anti-vascular endothelial growth […]

Written by: Edward H. Wood, MD September 2020 Wright LM, Harper A, Chang EY. Management of Infantile and Childhood Retinopathies: Optimized Pediatric Pars Plana Vitrectomy Sclerotomy Nomogram. Ophthalmol Retina. 2018 Dec;2(12):1227-1234. doi: 10.1016/j.oret.2018.06.008. Epub 2018 Aug 16. This excellent paper provides important surgical data for retina specialists taking care of pediatric patients. A relatively larger […]

Written by: Brian C. Toy, MD September 2020 EH Ryan, CM Ryan, NJ Forbes, et al. Primary Retinal Detachment Outcomes Study Report Number 2: Phakic Retinal Detachment Outcomes. Ophthalmology. 2020 Aug;127(8):1077-1085. doi: 10.1016/j.ophtha.2020.03.007. Epub 2020 Mar 9. The Primary Retinal Detachment Outcomes (PRO) Study assessed anatomic and visual outcomes among contemporary RRD cases performed employing SB, PPV, […]

Written by: Christian J. Sanfilippo, MD August 2020 Shah R, Simonett JM, Lyons RJ, Rao RC, Pennesi ME, Jain N. Disease course in patients with pentosan polysulfate sodium–associated maculopathy after drug cessation. JAMA Ophthalmol. Published online July 9, 2020. doi:10.1001/ jamaophthalmol.2020.2349 Pentosan polysulfate sodium (PPS) is the only FDA approved medication for the treatment of […]